Harvard Early Detection and Interception of Cancer Current Practice Recommendations and Novel Emerging Approaches 2025 (Videos)
$34
Encrypted checkout
Card payments protected
Drive download link
Private Google Drive access
Publisher-sourced files
Exact content as released
Responsive support
Help with access & files
Harvard Early Detection and Interception of Cancer Current Practice Recommendations and Novel Emerging Approaches 2025 (Videos)
Include: 1 videos, size: GB
Target Audience: oncologists, primary care physicians
Information:
Elevate your approach to cancer prevention with this dynamic course offering practical guidance on current screening practices, management of high-risk populations, and the integration of emerging early detection technologies into clinical care.
Through this course we will provide a comprehensive review of current cancer screening guidelines, provide guidance regarding high-risk populations and their management, educate regarding emerging technologies for early cancer detection, and provide referral pathways for complex patients.
Learning Objectives
- Identify and implement current cancer screening guidelines, with a focus on early detection and intervention for high-risk populations, and provide recommendations for managing these patients.
- Identify and establish appropriate referral pathways for patients with pre-malignant conditions requiring specialized care.
- Evaluate emerging technologies in cancer detection and assess their application for early detection of cancer.
Harvard’s “Early Detection and Interception of Cancer: Current Practice Recommendations and Novel Emerging Approaches” 2025 is best for clinicians, researchers, and healthcare professionals focused on cancer prevention, screening, and early intervention.
Here’s a detailed breakdown of who benefits most and what the program offers:
👩⚕️ Who Should Attend
- Primary care physicians and oncologists: To stay updated on best practices for cancer screening and risk management.
- Genetic counselors and specialists: To understand how emerging technologies impact hereditary cancer risk assessment.
- Medical researchers and public health professionals: To explore novel biomarkers, AI-driven diagnostics, and population-level strategies.
- Healthcare administrators and policy makers: To evaluate integration of new screening tools into clinical workflows and health systems.
- Advanced practice providers (NPs, PAs): To enhance their role in early detection and patient education.
🧬 What You’ll Learn
- Current screening guidelines for major cancers (e.g., breast, colorectal, lung).
- Management of high-risk populations, including those with genetic predispositions.
- Emerging technologies such as liquid biopsies, AI-powered imaging, and molecular diagnostics.
- Strategies for clinical integration of new tools and approaches into routine care.
+ Topics:
Monday, September 15, 2025
- 9:00-9:15 am Welcome and Kick Off Ben Ebert; Sapna Syngal; Betsy O’Donnell
- 9:15-9:45 am Whole Body Imaging for Screening and Early Detection of Cancer – Promises and Pitfalls Michael Rosenthal
- 9:45-10:00 am Management of DCIS (Ductal Carcinoma in SITU) and Other Breast Cancer Precursors Emily Gatof
- 10:00-10:15 am Genetics 101: Identification and Genetic Testing for Inherited Cancer Predisposition Elizabeth Kearns
- 10:15-10:30 am Management of Hereditary Cancer Predisposition in Your Practice Huma Rana
- 10:30-10:45 am Screening and Early Detection of Gynecologic Malignancies Colleen Feltmate
- 10:45-11:00 am Q&A Colleen Feltmate; Emily Gatof; Huma Rana; Elizabeth Kearns
- 11:00-11:15 am Break
- 11:15-11:30 am Screening and Early Detection of Dermatologic Malignancies Nicole Leboeuf
- 11:30-11:45 am Unexplained Cytopenia – When to Consider Clonal Hematopoiesis and Myelodysplastic Syndrome (MDS) Lachelle Weeks
- 11:45 am-12:00 pm Intercepting Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma Irene Ghobrial
- 12:00-12:15 pm Q&A Nicole Leboeuf; Lachelle Weeks; Irene Ghobrial
- 12:15-1:00 pm Lunch Break
- 1:00-1:15 pm Precursors to Head & Neck, Oral Cancers, and Management Glenn Hanna
- 1:15-1:30 pm Management of IPMNs, Barrett’s Esophagus and other Precursors to GI Cancer Nicolette Rodriguez
- 1:30-1:45 pm Screening and Early Detection of Lung Cancer Jacob Sands
- 1:45-2:00 pm Screening and Early Detection of Genitourinary Cancers Bicky Thapa
- 2:00-2:15 pm Q&A Nicolette Rodriguez; Jacob Sands; Glenn Hanna; Bicky Thapa
- 2:15-2:30 pm Break
- 2:30-2:45 pm Multi-Cancer Early Detection Tests – Ready for Prime Time? Betsy O’Donnell
- 2:45-3:00 pm Promoting Equity in Screening and Early Detection Timothy Rebbeck
- 3:00-3:15 pm Patient Experience with Multi-Cancer Early Detection Testing Karen Burns White
- 3:15-3:30 pm Panel Discussion: Looking to the Future of Early Detection and Interception Betsy O’Donnell; Timothy Rebbeck; Karen Burns White; Sapna Syngal
- 3:30-4:30 pm Networking Reception
Related products
